Investor Presentaiton slide image

Investor Presentaiton

Six strategic priorities ā˜‘ EXPAND THE GLP-1 MARKET AND WIN WITH SEMAGLUTIDE DRIVE INSULIN VOLUME AND VALUE SHARE BUILD THE GLOBAL OBESITY MARKET Investor presentation Full year 2018 Slide 29 RETURN TO GROWTH IN BIOPHARM DRIVE COMMERCIAL INNOVATION INNOVATE AND EXPAND PATIENT BASE novo nordisk
View entire presentation